JHP Pharmaceuticals

Warburg Pincus Acquires JHP Pharmaceuticals

The acquired company specializes in manufacturing and packaging of sterile injectable products.

JHP Pharmaceuticals LLC, a specialty pharmaceutical company that acquires, develops, manufactures and sells sterile injectable products, today announced that it has been acquired by an affiliate of Warburg Pincus, a leading global private equity firm focused on growth investing, from JHP Holdings, LLC, an entity majority-owned by Morgan Stanley Principal Investments, for $195 million on a debt-free, cash-free basis.  JHP's current management team will continue to hold an interest in the company. Additional terms of the transaction were not disclosed.

No votes yet
Syndicate content